共 50 条
Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment
被引:0
|作者:
Tabasi, Hamed
[1
,2
]
Mollazadeh, Samaneh
[3
]
Fazeli, Elham
[4
]
Abnus, Khalil
[1
]
Taghdisi, Seyed Mohammad
[2
]
Ramezani, Mohammad
[1
,2
]
Alibolandi, Mona
[1
,2
]
机构:
[1] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Pharmaceut Res Ctr, Mashhad, Iran
[2] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Mashhad, Iran
[3] North Khorasan Univ Med Sci, Nat Prod & Med Plants Res Ctr, Bojnurd, Iran
[4] Aarhus Univ, Biomed Dept, Aarhus, Denmark
关键词:
Oligonucleotide;
siRNA;
miRNA;
mRNA;
Cancer-therapy;
Immunotherapy;
MESOPOROUS SILICA NANOPARTICLES;
TARGETED SIRNA DELIVERY;
CO-DELIVERY;
STAT3;
SIRNA;
MIRNA OLIGONUCLEOTIDE;
EFFICIENT DELIVERY;
DOWN-REGULATION;
DRUG-DELIVERY;
COLON-CANCER;
LUNG-CANCER;
D O I:
10.1007/s12010-023-04597-5
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Conventional cancer therapies with chemodrugs suffer from various disadvantages, such as irreversible side effects on the skin, heart, liver, and nerves with even fatal consequences. RNA-based therapeutic is a novel technology which offers great potential as non-toxic, non-infectious, and well-tolerable platform. Herein, we introduce different RNA-based platforms with a special focus on siRNA, miRNA, and mRNA applications in cancer treatment in order to better understand the details of their therapeutic effects. Of note, the co-delivery of RNAs with other distinct RNA or drugs has provided safe, efficient, and novel treatment modalities for cancer treatment. [GRAPHICS] .
引用
收藏
页码:1685 / 1711
页数:27
相关论文